Home
Banking & Financial Services

Sector: Banking & Financial Services

A primer for IP-backed finance for growing companies

IP valuation and finance in Asia: where are we at?

Recipes for success in IP-backed finance

Latest content

Networking, reform, Japanese influx, NPE worries and much more as IPBC Global kicks off

The opening reception for this year’s IPBC Global took place on Sunday evening at the Palace Hotel in San Francisco. IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – are covering the event and below are a few…

15 June 2015

As the Innovation Act passes out of committee patent reform still lacks key industry support

Like its Senate counterpart last week, the Innovation Act comfortably passed out of committee yesterday after mark-up by the House Judiciary Committee. It did so, however, with notable concerns yet to be resolved. In separate statements the…

12 June 2015

World’s largest asset manager enters the IP financing game with wearables loan

BlackRock – the world’s biggest investment firm with over $4.6 trillion of assets under management – is loaning wearable technology company Jawbone $300 million against its intellectual property and other intangible assets. According to a Bloomberg…

22 May 2015

Monetisation options outside the courtroom are growing, but their ability to deliver remains open to question

If you’re a patent owner, monetising your IP in the US may seem like a tough task right now. The traditional licensing route has become so mired in litigation and re-exam challenges that it is increasingly only open to the richest plaintiffs. And…

14 May 2015

Despite increasing head winds Qualcomm’s high-quality patents continue to bring home the bacon

The transcript of Qualcomm’s recent investor call to discuss its latest quarterly results is a must-read for anyone in the licensing business. The giant chipmaker remains a pretty good bellwether for the market and has faced recent challenges over…

24 April 2015

Don't be surprised if big technology companies are next to feel the PTAB heat from investors

Given the important role that it now plays in so much US patent litigation, it is easy to forget that the Patent Trial and Appeal Board is not yet three years old. Established in September 2012 under a provision of the America Invents Act, the PTAB…

20 April 2015

A match made in heaven – IPNav founder and high-tech unite to save current PTAB claim standard?

If there is one area of patent reform where most US legislators seem able to agree, it’s that the Patent Trial and Appeal Board’s (PTAB) use of the broadest reasonable claim interpretation standard in interpreting patent claims should be abandoned…

16 April 2015

Philips LED deal shows that Chinese investors, as well as corporates, see the strategic power of IP assets

IAM readers keeping tabs on the LED industry will likely be aware of the recently announced deal which will see Philips sell the majority of its Lumileds lighting components unit to Chinese-led investment consortium GO Scale Capital for $3.3 billion…

13 April 2015

If pharma has high-quality patents IPRs should not be an issue, says hedge fund investor

Perhaps the patent story of the year so far has been the inter partes reviews (IPR) launched at the Patent Trial and Appeal Board (PTAB) against a series of pharmaceutical patents by hedge fund investors. Kyle Bass, founder of Hayman Capital…

09 April 2015

Bass/Spangenberg file new pharma IPR re-exams

Hedge fund investor Kyle Bass and former IPNav CEO Erich Spangenberg have filed inter partes reviews against patents owned by Shire Pharmaceuticals and NPS Pharmaceuticals. The Irish headquartered Shire recently bought NPS in a $5.2bn deal. Its…

02 April 2015

Unlock unlimited access to all IAM content